The in vitro effect of amrinone on thromboxane B2 synthesis in human whole blood
- 1 June 1986
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 42 (6) , 817-824
- https://doi.org/10.1016/0049-3848(86)90118-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- PLATELET AND VASCULAR ARACHIDONIC ACID METABOLITES: CAN THEY HELP DETECT A TENDENCY TOWARDS THROMBOSIS?British Journal of Haematology, 1984
- Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase productsBlood, 1984
- The effects of amrinone on platelet count, survival and function in patients with congestive cardiac failure.British Journal of Clinical Pharmacology, 1984
- Amrinone A Preliminary Review of its Pharmacological Properties and Therapeutic UseDrugs, 1983
- Mechanism of action of amrinone: Role of thromboxane synthetase inhibitionProstaglandins, Leukotrienes and Medicine, 1983
- A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2Thrombosis Research, 1982
- THROMBOXANE SYNTHETASE INHIBITION AS ANTITHROMBOTIC STRATEGYThe Lancet, 1981
- INHIBITION OF THROMBOXANE SYNTHETASE DOES NOT NECESSARILY PREVENT PLATELET AGGREGATIONThe Lancet, 1981
- Effect of amrinone, a cardiotonic drug, on hemodynamics and platelet functionProstaglandins and Medicine, 1981
- INHIBITION OF PLATELET-FUNCTION BY ANTI-THROMBOTIC AGENTS WHICH SELECTIVELY INHIBIT LOW-KM CYCLIC 3',5'-ADENOSINE-MONOPHOSPHATE PHOSPHODIESTERASE1980